(Q44018901)

English

Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal

scientific article published in June 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Ram H Nagaraj

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pratishruti Sarkar

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Anirudh Mally

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Klaus M Biemel

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Markus O Lederer

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pius S Padayatti

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Archives of Biochemistry and Biophysics

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

402

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

110-119

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

The glyoxalase system in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Hospital admissions of adolescent patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Chromatographic quantification of argpyrimidine, a methylglyoxal-derived product in tissue proteins: comparison with pentosidine

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Exact mass measurement of polar organic molecules at low resolution using electrospray ionization and a quadrupole mass spectrometer

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Maillard reactions in lens proteins: methylglyoxal-mediated modifications in the rat lens

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Methylglyoxal concentration and glyoxalase activities in the human lens

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Effect of factors of favism on the protein and lipid components of rat erythrocyte membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Lipid peroxidation and activity of antioxidant enzymes in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Methylglyoxal-modified arginine residues — a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Chelating activity of advanced glycation end-product inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Pyridoxine and pyridoxamine inhibits superoxide radicals and prevents lipid peroxidation, protein glycosylation, and (Na+ + K+)-ATPase activity reduction in high glucose-treated human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2802%2900067-X

7 January 2021

Identifiers

10.1016/S0003-9861(02)00067-X

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44018901&oldid=2105686411"